Global burden of disease attributable to illicit drug use and dependence: findings from the global burden of disease study, Lancet, vol.382, pp.1564-1574, 2010. ,
Changing dynamics of the drug overdose epidemic in the United States from 1979 through, Science, vol.361, issue.6408, p.1184, 2016. ,
Drug-poisoning deaths involving heroin: united States, NCHS Data Brief, vol.190, pp.1-8, 2000. ,
Drug-poisoning deaths involving opioid analgesics: United States, NCHS Data Brief, issue.166, pp.1-8, 1999. ,
Drug and opioid-involved overdose deaths -United States, MMWR Morb Mortal Wkly Rep, vol.67, pp.1419-1427, 2018. ,
Prevention and treatment of opioid misuse and addiction: a review, JAMA Psychiatry, vol.76, pp.208-216, 2019. ,
Prescription opioid misuse and public health approach in Australia, Subst Use Misuse, vol.53, pp.200-205, 2018. ,
Opioid Therapy in Acute and Chronic Pain, J Clin Pharmacol, vol.58, issue.9, pp.1111-1122, 2018. ,
Pharmacologic treatment of opioid use disorder: a review of pharmacotherapy, adjuncts, and toxicity, J Med Toxicol, vol.14, pp.306-322, 2018. ,
Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opioid dependence: a randomized clinical noninferiority trial, JAMA Psychiatry, vol.74, issue.12, pp.1197-1205, 2017. ,
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial, Lancet, vol.391, pp.309-318, 2018. ,
Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years, Eur J Pharmacol, vol.836, pp.89-101, 2018. ,
Methadone maintenance 4 decades later: thousands of lives saved but still controversial, JAMA, vol.300, pp.2303-2305, 2008. ,
A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride, JAMA, vol.193, pp.646-650, 1965. ,
,
, Ann Med Internet (Paris), vol.125, pp.447-452, 1974.
,
, Ann Med Internet (Paris), vol.125, pp.459-462, 1974.
, Alderks CE Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment Facilities: 2003-2015 (update). The CBHSQ Report
, Substance Abuse and Mental Health Services Administration (US), 2013.
Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial: outcomes of buprenorphine versus methadone, Addiction, vol.111, pp.695-705, 2016. ,
Opioid agonist treatment for patients with dependence on prescription opioids, JAMA, vol.317, pp.967-968, 2017. ,
Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index, J Clin Psychopharmacol, vol.16, pp.58-67, 1996. ,
Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus, Expert Opin Pharmacother, vol.18, pp.1987-1999, 2017. ,
European expert-based guidance for using OMTs ,
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies, BMJ, vol.357, p.1550, 2017. ,
Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health-related quality of life assessment, Addiction, vol.98, pp.693-702, 2003. ,
Quality of life among heroin users on buprenorphine versus methadone maintenance, Am J Drug Alcohol Abuse, vol.33, pp.631-642, 2007. ,
Associations between methadone maintenance treatment and crime: a 17-year longitudinal cohort study of Canadian provincial offenders, Addiction, vol.113, pp.656-667, 2018. ,
The cost-effectiveness of methadone maintenance as a health care intervention, Addiction, vol.94, pp.479-488, 1999. ,
Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial, Drug Alcohol Depend, vol.174, pp.181-191, 2017. ,
Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone, Int J Drug Policy, vol.46, pp.54-60, 2017. ,
Medication for opioid use disorder after nonfatal opioid overdose and association with mortality, Ann Intern Med, vol.169, p.137, 2018. ,
Phases of treatment: a practical approach to methadone maintenance treatment, Int J Addict, vol.29, pp.135-160, 1994. ,
Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1, Mol Psychiatry, vol.22, pp.346-352, 2017. ,
Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity, Br J Clin Pharmacol, vol.79, pp.967-977, 2015. ,
Factors associated with methadone maintenance therapy discontinuation among people who inject drugs, J Subst Abuse Treat, vol.94, pp.41-46, 2018. ,
Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study, Lancet Psychiatry, vol.2, pp.901-908, 2015. ,
A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world, J Addict Med, vol.8, pp.315-326, 2014. ,
County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States, J Acquir Immune Defic Syndr, vol.73, pp.323-331, 2016. ,
Increases from 2002 to 2015 in prescription opioid overdose deaths in combination with other substances, Drug Alcohol Depend, vol.178, pp.501-511, 2017. ,
Methadone in primary care -one small step for congress, one giant leap for addiction treatment, N Engl J Med, vol.379, pp.7-8, 2018. ,
Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies, Drug Alcohol Depend, vol.191, pp.1-5, 2018. ,
, Portugal): treatment, EMCDDA. Country drug report, vol.2018, 2018.
French field experience with buprenorphine, Am J Addict, vol.13, issue.1, pp.17-28, 2004. ,
, ? Historical article on the French model of OMTs
Why buprenorphine is so successful in treating opiate addiction in France, Curr Psychiatry Rep, vol.9, pp.358-364, 2007. ,
, ? Another important article on the French model of OMTs
Trend in buprenorphine and methadone shopping behavior in France from, 2004. ,
, Presse Med, vol.45, pp.369-375, 2016.
Management of opioid addiction with buprenorphine: french history and current management, Int J Gen Med, vol.7, pp.143-148, 2014. ,
, Another important and the most recent article on the French model of OMTs
,
, Therapie, vol.73, pp.511-520, 2018.
Temporary approval for intranasal naloxone: setting up in a French addiction center ,
, Therapie, vol.73, pp.495-500, 2018.
, Country drug report 2018 (France): treatment, EMCDDA, 2018.
Buprenorphine implants in medical treatment of opioid addiction, Expert Rev Clin Pharmacol, vol.10, issue.8, pp.799-807, 2017. ,
, ?? An important review encompassing all buprenorphine implants for opioid dependence
Buvidal: summary of product characteristics, 2018. ,
, Buvidal assessment report from the committee for medicinal products for human use (CHMP), ?? The most important pieces of information to know on Buvidal® 51. EMA: European Medicines Agency, 2018.
Weekly and monthly subcutaneous buprenorphine depot formulations vs daily sublingual buprenorphine with naloxone for treatment of opioid use disorder: a randomized clinical trial, JAMA Intern Med, vol.178, pp.764-773, 2018. ,
Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult outpatients with opioid use disorder, Addiction, vol.114, issue.8, pp.1416-1426, 2019. ,
Effect of buprenorphine weekly depot (CAM2038) and hydromorphone blockade in individuals with opioid use disorder: a randomized clinical trial, JAMA Psychiatry, vol.74, pp.894-902, 2017. ,
Implants and depot injections for treating opioid dependence: qualitative study of people who use or have used heroin, Drug Alcohol Depend, vol.189, pp.1-7, 2018. ,
Prolonged-release opioid agonist therapy: qualitative study exploring patients' views of 1-week, 1-month, and 6-month buprenorphine formulations, Harm Reduct J, vol.16, p.25, 2019. ,
Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification, Addiction, vol.99, pp.718-726, 2004. ,
Alcohol use in opioid agonist treatment, Addict Sci Clin Pract, vol.11, p.17, 2016. ,